IFP Advisors’s CorMedix CRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$30.1K Buy
3,909
+102
+3% +$817 ﹤0.01% 2714
2026
Q2
$29.9K Buy
3,807
+1,056
+38% +$8.34K ﹤0.01% 2726
2026
Q1
$18.7K Buy
+2,751
New +$20.3K ﹤0.01% 2815
2025
Q3
– Sell
-9
Closed -$677 – 4852
2025
Q2
$677 Buy
+9
New +$99 ﹤0.01% 4343
2025
Q1
– Sell
-5
Closed -$40 – 4384
2024
Q4
$40 Buy
+5
New +$50 ﹤0.01% 4316

Other funds holding CRMD

IFP Advisors's CRMD Position: Q3 2026 in Review

IFP Advisors increased its CorMedix (CRMD) stake by 2.7% in Q3 2026, buying an estimated $817 and bringing the position to 3,909 shares worth $30.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2714.

IFP Advisors first reported a position in CRMD in Q4 2024 and has held it in 5 quarters since. 189 funds tracked by Wall St. Rank hold CRMD as of Q3 2026.

  • IFP Advisors held 3,909 shares of CorMedix worth $30.1K as of Q3 2026.
  • IFP Advisors bought 102 CorMedix shares in Q3 2026, an estimated $817.
  • CorMedix made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #2714 holding.
  • IFP Advisors first reported a position in CorMedix in Q4 2024 and has held it in 5 quarters since.
  • 189 funds tracked by Wall St. Rank held CorMedix as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.